Prophylaxis against CMV infection in transplant patients.
Griffiths
P D
PD
Department of Virology, Royal Free Hospital School of Medicine, London, UK.
D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003586:Cytomegalovirus Infections / Q000097:blood / Q000188:drug therapy / Q000517:prevention & control* / Q000652:urine; D015774:Ganciclovir / Q000627:therapeutic use; D016027:Heart Transplantation; D006801:Humans; D016031:Liver Transplantation; D008991:Monitoring, Physiologic; D016377:Organ Transplantation; D012307:Risk Factors; D019562:Viral Load; D014766:Viremia / Q000097:blood
D000998:Antiviral Agents; D015774:Ganciclovir; D000212:Acyclovir